Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 237

1.

Meta-Analyses of Association Between BRAF(V600E) Mutation and Clinicopathological Features of Papillary Thyroid Carcinoma.

Zhang Q, Liu SZ, Zhang Q, Guan YX, Chen QJ, Zhu QY.

Cell Physiol Biochem. 2016;38(2):763-76. doi: 10.1159/000443032. Epub 2016 Feb 15.

2.

BRAF V600E mutation and its association with clinicopathological features of papillary thyroid cancer: a meta-analysis.

Li C, Lee KC, Schneider EB, Zeiger MA.

J Clin Endocrinol Metab. 2012 Dec;97(12):4559-70. doi: 10.1210/jc.2012-2104. Epub 2012 Oct 9.

3.

Clinicopathological Features and Prognosis of Papillary Thyroid Microcarcinoma for Surgery and Relationships with the BRAFV600E Mutational Status and Expression of Angiogenic Factors.

Shi C, Guo Y, Lv Y, Nanding A, Shi T, Qin H, He J.

PLoS One. 2016 Dec 9;11(12):e0167414. doi: 10.1371/journal.pone.0167414. eCollection 2016.

4.

The association between BRAF (V600E) mutation and pathological features in PTC.

Liu X, Yan K, Lin X, Zhao L, An W, Wang C, Liu X.

Eur Arch Otorhinolaryngol. 2014 Nov;271(11):3041-52. doi: 10.1007/s00405-013-2872-7. Epub 2014 Jan 4. Review.

PMID:
24389984
5.

Association between BRAF V600E mutation and mortality in patients with papillary thyroid cancer.

Xing M, Alzahrani AS, Carson KA, Viola D, Elisei R, Bendlova B, Yip L, Mian C, Vianello F, Tuttle RM, Robenshtok E, Fagin JA, Puxeddu E, Fugazzola L, Czarniecka A, Jarzab B, O'Neill CJ, Sywak MS, Lam AK, Riesco-Eizaguirre G, Santisteban P, Nakayama H, Tufano RP, Pai SI, Zeiger MA, Westra WH, Clark DP, Clifton-Bligh R, Sidransky D, Ladenson PW, Sykorova V.

JAMA. 2013 Apr 10;309(14):1493-501. doi: 10.1001/jama.2013.3190.

6.

Chronic lymphocytic thyroiditis and BRAF V600E in papillary thyroid carcinoma.

Kim SK, Woo JW, Lee JH, Park I, Choe JH, Kim JH, Kim JS.

Endocr Relat Cancer. 2016 Jan;23(1):27-34. doi: 10.1530/ERC-15-0408.

PMID:
26598713
7.

Association between BRAF V600E mutation and regional lymph node metastasis in papillary thyroid carcinoma.

Lu J, Gao J, Zhang J, Sun J, Wu H, Shi X, Teng L, Liang Z.

Int J Clin Exp Pathol. 2015 Jan 1;8(1):793-9. eCollection 2015.

8.

Correlation among the BRAF gene mutation status, clinicopathological features of primary tumour, and lymph node metastasizing of papillary thyroid carcinoma.

Lukas J, Drabek J, Dudesek B, Vazan P, Stranska J, Jancik S, Mackova M, Syrucek M, Lukas D, Duskova J, Dundr P, Hintnausova B, Jiskra J.

Exp Clin Endocrinol Diabetes. 2014 May;122(5):268-72. doi: 10.1055/s-0034-1372624. Epub 2014 May 16.

PMID:
24839220
9.

BRAF(V⁶⁰⁰E) mutation and its association with clinicopathological features of papillary thyroid microcarcinoma: A meta-analysis.

Ma YJ, Deng XL, Li HQ.

J Huazhong Univ Sci Technolog Med Sci. 2015 Aug;35(4):591-599. doi: 10.1007/s11596-015-1476-4. Epub 2015 Jul 31.

PMID:
26223933
10.

The role of BRAF V600E mutation as a potential marker for prognostic stratification of papillary thyroid carcinoma: a long-term follow-up study.

Daliri M, Abbaszadegan MR, Bahar MM, Arabi A, Yadollahi M, Ghafari A, Taghehchian N, Zakavi SR.

Endocr Res. 2014;39(4):189-93. doi: 10.3109/07435800.2013.879169. Epub 2014 Mar 28.

PMID:
24679337
11.

The synergic effect of BRAFV600E mutation and multifocality on central lymph node metastasis in unilateral papillary thyroid carcinoma.

Qu HJ, Qu XY, Hu Z, Lin Y, Wang JR, Zheng CF, Tan Z.

Endocr J. 2018 Jan 30;65(1):113-120. doi: 10.1507/endocrj.EJ17-0110. Epub 2017 Oct 26.

12.

Associations between BRAF(V600E) and prognostic factors and poor outcomes in papillary thyroid carcinoma: a meta-analysis.

Liu C, Chen T, Liu Z.

World J Surg Oncol. 2016 Sep 6;14(1):241. doi: 10.1186/s12957-016-0979-1.

13.

The relationship of the BRAF(V600E) mutation and the established prognostic factors in papillary thyroid carcinomas.

Kurt B, Yalçın S, Alagöz E, Karslıoğlu Y, Yigit N, Günal A, Deveci MS.

Endocr Pathol. 2012 Sep;23(3):135-40. doi: 10.1007/s12022-012-9218-7.

PMID:
22767446
14.

The association of the BRAF(V600E) mutation with prognostic factors and poor clinical outcome in papillary thyroid cancer: a meta-analysis.

Kim TH, Park YJ, Lim JA, Ahn HY, Lee EK, Lee YJ, Kim KW, Hahn SK, Youn YK, Kim KH, Cho BY, Park DJ.

Cancer. 2012 Apr 1;118(7):1764-73. doi: 10.1002/cncr.26500. Epub 2011 Aug 31.

15.

Impact of clinical risk scores and BRAF V600E mutation status on outcome in papillary thyroid cancer.

Niederer-Wüst SM, Jochum W, Förbs D, Brändle M, Bilz S, Clerici T, Oettli R, Müller J, Haile SR, Ess S, Stoeckli SJ, Broglie MA.

Surgery. 2015 Jan;157(1):119-25. doi: 10.1016/j.surg.2014.07.015.

PMID:
25482468
16.

BRAF V600E mutation is associated with tumor aggressiveness in papillary thyroid cancer.

Kim SJ, Lee KE, Myong JP, Park JH, Jeon YK, Min HS, Park SY, Jung KC, Koo do H, Youn YK.

World J Surg. 2012 Feb;36(2):310-7. doi: 10.1007/s00268-011-1383-1.

PMID:
22190222
17.

The BRAF(V600E) mutation is an independent, poor prognostic factor for the outcome of patients with low-risk intrathyroid papillary thyroid carcinoma: single-institution results from a large cohort study.

Elisei R, Viola D, Torregrossa L, Giannini R, Romei C, Ugolini C, Molinaro E, Agate L, Biagini A, Lupi C, Valerio L, Materazzi G, Miccoli P, Piaggi P, Pinchera A, Vitti P, Basolo F.

J Clin Endocrinol Metab. 2012 Dec;97(12):4390-8. doi: 10.1210/jc.2012-1775. Epub 2012 Oct 12.

PMID:
23066120
18.

BRAFV600E mutation in fine-needle aspiration aspirates: Association with poorer prognostic factors in larger papillary thyroid carcinomas.

Lee JI, Jang HW, Kim SW, Kim JW, Oh YL, Chung JH.

Head Neck. 2013 Apr;35(4):548-53. doi: 10.1002/hed.22997. Epub 2012 Apr 7.

PMID:
22488961
19.

Association of BRAF V600E Mutation and MicroRNA Expression with Central Lymph Node Metastases in Papillary Thyroid Cancer: A Prospective Study from Four Endocrine Surgery Centers.

Han PA, Kim HS, Cho S, Fazeli R, Najafian A, Khawaja H, McAlexander M, Dy B, Sorensen M, Aronova A, Sebo TJ, Giordano TJ, Fahey TJ 3rd, Thompson GB, Gauger PG, Somervell H, Bishop JA, Eshleman JR, Schneider EB, Witwer KW, Umbricht CB, Zeiger MA.

Thyroid. 2016 Apr;26(4):532-42. doi: 10.1089/thy.2015.0378. Epub 2016 Mar 7.

20.

BRAF(V600E) Mutation is Associated with Decreased Disease-Free Survival in Papillary Thyroid Cancer.

Fraser S, Go C, Aniss A, Sidhu S, Delbridge L, Learoyd D, Clifton-Bligh R, Tacon L, Tsang V, Robinson B, Gill AJ, Sywak M.

World J Surg. 2016 Jul;40(7):1618-24. doi: 10.1007/s00268-016-3534-x.

PMID:
27138882

Supplemental Content

Support Center